Phase III study of N4-behenoyl-l-beta-D-arabinofuranosylcytosine in adult acute leukemia-BH-AC-DMP therapy.
D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D003561:Cytarabine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D003630:Daunorubicin / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007938:Leukemia / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D011239:Prednisolone / Q000627:therapeutic use; D013868:Thioinosine / Q000627:therapeutic use
D003561:Cytarabine; D013868:Thioinosine; D011239:Prednisolone; C015019:enocitabine; D003630:Daunorubicin